- Home
- SRZN vs FOA Comparison
SRZN vs FOA Comparison
Compare SRZN & FOA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | SRZN | FOA |
|---|---|---|
| Founded | 2015 | 2013 |
| Country | United States | United States |
| Employees | 59 | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Finance Companies |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 276.3M | 221.6M |
| IPO Year | 2020 | 2021 |
Fundamental Metrics
Financial Performance| Metric | SRZN | FOA |
|---|---|---|
| Price | $25.83 | $11.57 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 6 | 3 |
| Target Price | ★ $48.40 | $31.00 |
| AVG Volume (30 Days) | ★ 942.2K | 63.8K |
| Earning Date | 11-06-2026 | 11-03-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 216.95 |
| EPS | N/A | ★ 0.41 |
| Revenue | $3,477,000.00 | ★ $497,432,000.00 |
| Revenue This Year | $208.89 | N/A |
| Revenue Next Year | N/A | $23.05 |
| P/E Ratio | ★ N/A | $26.59 |
| Revenue Growth | N/A | ★ 47.09 |
| 52 Week Low | $11.39 | $10.63 |
| 52 Week High | $37.83 | $29.79 |
Technical Indicators
Market Signals| Indicator | SRZN | FOA |
|---|---|---|
| Relative Strength Index (RSI) | 52.22 | 31.24 |
| Support Level | $23.31 | N/A |
| Resistance Level | $28.78 | $15.40 |
| Average True Range (ATR) | 2.74 | 0.68 |
| MACD | -0.34 | 0.09 |
| Stochastic Oscillator | 43.37 | 28.81 |
Price Performance
Historical ComparisonAbout SRZN Surrozen Inc.
Surrozen Inc is a clinical-stage biotechnology company committed to discovering and developing drug candidates to selectively modulate the Wnt pathway, a critical mediator of tissue repair, in a broad range of organs and tissues. Its product candidate includes SZN-8141(for wet AMD, DME), SZN-413( For retinopathies) and SZN-8143 (for wet AMD, DME, UME).
About FOA Finance of America Companies Inc.
Finance of America Companies Inc provides home equity-based financing solutions for modern retirement and offers capital markets and portfolio management capabilities to optimize loan distribution to investors. The Company operates through two segments: Retirement Solutions and Portfolio Management. The Retirement Solutions segment handles loan origination, including HECM and non-agency reverse mortgage loans, generating revenue from origination fees and initial gains, with loans transferred to the Portfolio Management segment. The Portfolio Management segment, which generates the majority of revenue, provides securitization, loan sales, risk management, and asset management services, and earns revenue from net interest income, fair value changes, and servicing-related income.